Advertisement

Nachweis einer Infektion mit Humanem Immundefizienzvirus (HIV): Serologisches Screening mit nachfolgender Bestätigungsdiagnostik durch Antikörper-basierte Testsysteme und/oder durch HIV-Nukleinsäure-Nachweis

Stellungnahme der Gemeinsamen Diagnostikkommission der Deutschen Vereinigung zur Bekämpfung von Viruskrankheiten e. V.(DVV e. V.) und der Gesellschaft für Virologie e. V. (GfV e. V.)
Mitteilungen

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. 1.
    Ananworanich J, Fletcher JL, Pinyakorn S, van Griensven F, Vandergeeten C, Schuetz A, Pankam T, Trichavaroj R, Akapirat S, Chomchey N, Phanuphak P, Chomont N, Michael NL, Kim JH, de Souza M, RV254/SEARCH 010 Study Group (2013) A novel acute HIV infection staging system based on 4th generation immunoassay. Retrovirology 10:56CrossRefPubMedPubMedCentralGoogle Scholar
  2. 2.
    AWMF-Leitlinie: Deutsch-Österreichische Leitlinie zur HIV-Therapie in der Schwangerschaft und bei HIV-exponierten Neugeborenen. AWMF-Register-Nr.: 055-002. Stand Mai 2014. http://www.awmf.org/uploads/tx_szleitlinien/055-002l_S 2k_HIV-Therapie_Schwangerschaft_Neugeborenen_2014-05.pdf
  3. 3.
    Bundesamt für Gesundheit. Das schweizerische HIV Testkonzept – eine aktualisierte Übersicht. BAG Bulletin, 18.11.2013: 6-14. http://www.bag.admin.ch/hiv_aids/12472/12474/index.html?lang=de
  4. 4.
    Butler KM, Gavin P, Coughlan S, Rochford A, Donagh SM, Cunningham O, Poulsom H, Watters S, Klein N (2015) Rapid viral rebound after 4 years of suppressive therapy in a seronegative HIV-1 infected infant treated from birth. Pediatr Infect Dis J 34:e48–e51CrossRefPubMedGoogle Scholar
  5. 5.
    Chin BS, Lee SH, Kim KJ, Kee MK, Suh SD, Kim SS (2007) Early identification of seronegative human immunodeficiency virus type 1 infection with severe presentation. J Clin Microbiol 45:1659–1662CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Chudy M, Kress J, Halbauer J, Heiden M, Funk MB, Nübling CM (2014) Risk minimization measures for blood screening HIV-1 nucleic acid amplification technique assays in Germany. Transfus Med Hemother 41:45–51CrossRefPubMedGoogle Scholar
  7. 7.
    Fiebig EW, Wright DJ, Rawal BD, Garrett PE, Schumacher RT, Peddada L, Heldebrant C, Smith R, Conrad A, Kleinman SH, Busch MP (2003) Dynamics of HIV viremia and antibody seroconversion in plasma donors: implications for diagnosis and staging of primary HIV infection. Aids 17:1871–1879CrossRefPubMedGoogle Scholar
  8. 8.
    Genovese L, Nebuloni M, Alfano M (2013) Cell mediated immunity in elite controllers naturally controlling HIV viral load. Front Immunol 4:86. doi:10.3389/fimmun.2013.00086.eCollection2013CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    Gökengin D, Geretti AM, Begovac J, Palfreeman A, Stevanovic M, Tarasenko O, Radcliffe K (2014) 2014 European Guideline on HIV testing. Int J STD AIDS 25:695–704CrossRefPubMedGoogle Scholar
  10. 10.
    Habermehl KO, Maas G (1992) Interpretation der Immunoblots zum Nachweis von Antikörpern gegen HIV-1 und HIV-2. Dt Ärztebl 89(34/35):A1 2775–2776Google Scholar
  11. 11.
    Kahn JO, Walker BD (1998) Acute human immunodeficiency virus type 1 infection. N Engl J Med 339(1):33–39CrossRefPubMedGoogle Scholar
  12. 12.
    Li YC, Yang F, Ji XY, Fang ZJ, Liu J, Wang Y (2014) False human immunodeficiency virus test results associated with rheumatoid factors in rheumatoid arthritis. Chin Med Sci J 29(2):103–106CrossRefPubMedGoogle Scholar
  13. 13.
    Ly TD, Laperche S, Couroucé AM (2001) Early detection of human immunodeficiency virus infection using third- and fourth-generation screening assays. Eur J Clin Microbiol Infect Dis 20(2):104–110PubMedGoogle Scholar
  14. 14.
    Ly TD, Plantier JC, Leballais L, Gonzalo S, Lemée V, Laperche S (2012) The variable sensitivity of HIV Ag/Ab combination assays in the detection of p24Ag according to genotype could compromise the diagnosis of early HIV infection. J Clin Virol 55(2):121–127CrossRefPubMedGoogle Scholar
  15. 15.
    Michael NL, Brown AE, Voigt RF, Frankel SS, Mascola JR, Brothers KS, Louder M, Birx DL, Cassol SA (1997) Rapid disease progression without seroconversion following primary human immunodeficiency virus type 1 infection – evidence for highly susceptible human hosts. J Infect Dis 175:1352–1359CrossRefPubMedGoogle Scholar
  16. 16.
    Okomo U, Toqun T, Oko F, Peterson K, Townend J, Peterson I, Jave A (2012) Treatment outcomes among HIV-1 and HIV-2 infected children initiating antiretroviral therapy in a concentrated low prevalence setting in West Africa. BMC Pediatr 12:95. doi:10.1186/1471-2431-12-95CrossRefPubMedPubMedCentralGoogle Scholar
  17. 17.
    Tipple C, Oomeer S, Dosekun O, Mackie N (2014) Service impact of a change in HIV-1 viral load quantification assay. J Int AIDS Soc 17(4 Suppl 3):19677. doi:10.7448/IAS. 17.4.19677.eCollection 2014PubMedPubMedCentralGoogle Scholar
  18. 18.
    Vetter BN, Shah C, Huder JB, Böni J, Schüpbach J (2014) Use of reverse-transcriptase-based HIV-1 viral load assessment to confirm low viral loads in newly diagnosed patients in Switzerland. BMC Infect Dis 14:84. doi:10.1186/1471-2334-14-84CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2015

Personalised recommendations